advertisement
Home » News » Dual Psychotherapies Can Ease OCD When Drugs Fail
Dual Psychotherapies Can Ease OCD When Drugs Fail

Dual Psychotherapies Can Ease OCD When Drugs Fail

New research suggests a treatment regimen that combines exposure and response prevention therapy can help patients with obsessive-compulsive disorder (OCD) when common drug treatment options fail.

Exposure and response prevention therapy is a type of cognitive-behaviora; therapy in which the patient is asked to confront triggers that give rise to their obsessions in order to refrain from performing the rituals in response to these obsessions.

The study is published in the Journal of Clinical Psychiatry.

OCD is marked by the performing of “rituals” to decrease distress related to one’s obsessions, such as excessive hand-washing to cope with a fixation on hand hygiene, for example.

“We know that exposure and response prevention therapy (EX/RP) can benefit these patients,” said lead author Carmen McLean, Ph.D., an assistant professor of clinical psychology at the Perelman School of Medicine — University of Pennsylvania.

Traditional treatment regimens often combine pharmacological treatment and exposure therapy/response prevention therapy for people with OCD.

“But this study showed that EX/RP is also effective for OCD sufferers who do not benefit sufficiently from common drug treatments for OCD.”

A previous study compared the effects of adding risperidone, pill placebo, and up to 17 twice-weekly therapist-led sessions of EX/RP to medication for OCD.

“We found compared to patients who received medication or placebo, those who received EX/RP showed significantly more reductions in OCD symptoms and depression, as well as significantly more increases in insight, quality of life, and social function after only eight weeks,” McLean said.

The current study included 32 patients who crossed over to receive 17 weeks of EX/RP treatment after not benefitting sufficiently from risperidone.

Evaluation at 12 and 16 weeks showed significant symptom improvement, with 25 (78 percent) of patients completing treatment; 17 (53 percent) of them were classified as treatment responders and 11 (34 percent) classified as excellent responders at a 32-week follow-up evaluation.

The remaining patients required medication changes during the follow-up period, which enabled them to shift to excellent-responder status.

This study adds to the large body of research that shows the benefits of exposure therapy for patients with OCD.

“We want patients to know that there is another option, if common drug treatments have failed them,” said senior author Edna Foa, Ph.D., professor of clinical psychology in the department of psychiatry and the creator of exposure therapy.

“The therapy can be life-saving, if patients are aware of it.”

Source: University of Pennsylvania
 
Man in therapy photo by shutterstock.

Dual Psychotherapies Can Ease OCD When Drugs Fail

Rick Nauert PhD

Rick Nauert, PhDDr. Rick Nauert has over 25 years experience in clinical, administrative and academic healthcare. He is currently an associate professor for Rocky Mountain University of Health Professionals doctoral program in health promotion and wellness. Dr. Nauert began his career as a clinical physical therapist and served as a regional manager for a publicly traded multidisciplinary rehabilitation agency for 12 years. He has masters degrees in health-fitness management and healthcare administration and a doctoral degree from The University of Texas at Austin focused on health care informatics, health administration, health education and health policy. His research efforts included the area of telehealth with a specialty in disease management.

APA Reference
Nauert PhD, R. (2015). Dual Psychotherapies Can Ease OCD When Drugs Fail. Psych Central. Retrieved on September 25, 2018, from https://psychcentral.com/news/2015/11/12/exposureresponse-prevention-therapy-is-an-option-for-ocd/94749.html

 

Scientifically Reviewed
Last updated: 12 Nov 2015
Last reviewed: By John M. Grohol, Psy.D. on 12 Nov 2015
Published on PsychCentral.com. All rights reserved.